Acetazolamide (acetazolamide)

Acetazolamide is a carbonic anhydrase inhibitor.

Acetazolamide shares the uses of the carbonic anhydrase inhibitors; however, the extended-release capsules are intended for use only for the adjunctive treatment of open-angle (noncongestive, chronic simple) or secondary glaucoma, for short-term preoperative therapy in angle-closure glaucoma (obstructive, narrow-angle) when delay of surgery is desired in order to lower intraocular pressure (IOP), and for prevention or amelioration of symptoms associated with acute high-altitude sickness (mountain sickness). Long-term use of oral carbonic anhydrase inhibitors in the treatment of glaucoma is limited by systemic adverse effects. (See Uses: Glaucoma, in the Carbonic Anhydrase Inhibitors General Statement 52:40.12.)

Generic name: acetazolamide
Pronunciation: (a-SEET-a-ZOE-la-mide)

The following indications are listed for Acetazolamide:

• Absence Epilepsy
• Angle-Closure Glaucoma
• Anoxia Due To High Altitude
• Edema
• Malignant Glaucoma
• Open Angle Glaucoma
• Peripheral Edema
• Peripheral Edema Due To Chronic Heart Failure
• Secondary Glaucoma

Also known as: Absence Epilepsy Simple, Absence Seizures, Acosta's Disease, Acute Mountain Sickness, Chronic Glaucoma, Compensated Glaucoma, Edema Of Extremities, Edematous Sodium Retaining Conditions, Glaucoma Simplex, Hypobaropathy, Minor Epilepsy, Narrow Angle Glaucoma, Open-Angle Glaucoma, Peripheral Edema Due To Chf, Peripheral Edema Due To Congestive Heart Failure, Petit Mal Epilepsy, Simple Glaucoma.

No ICD codes are available for this drug.